Andrea Bezjak
#167,178
Most Influential Person Now
Researcher
Andrea Bezjak's AcademicInfluence.com Rankings
Andrea Bezjaklaw Degrees
Law
#2829
World Rank
#3520
Historical Rank
Common Law
#157
World Rank
#170
Historical Rank
International Law
#830
World Rank
#1007
Historical Rank
Andrea Bezjakengineering Degrees
Engineering
#7440
World Rank
#8814
Historical Rank
Biomedical Engineering
#750
World Rank
#762
Historical Rank
Applied Physics
#2585
World Rank
#2626
Historical Rank
Download Badge
Law Engineering
Why Is Andrea Bezjak Influential?
(Suggest an Edit or Addition)Andrea Bezjak's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Erlotinib in previously treated non-small-cell lung cancer. (2005) (4245)
- Stereotactic body radiation therapy for inoperable early stage lung cancer. (2010) (2246)
- Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. (2003) (521)
- Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. (2004) (496)
- Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. (2003) (438)
- Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial (2017) (326)
- Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. (2007) (320)
- Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. (2005) (319)
- Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. (2006) (309)
- Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. (2011) (293)
- Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. (2005) (260)
- A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy. A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial (2004) (246)
- Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group. (2003) (245)
- The Management of Thymoma: A Systematic Review and Practice Guideline (2009) (242)
- Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. (2002) (242)
- Interpreting clinically significant changes in patient‐reported outcomes (2007) (240)
- Palliative thoracic radiotherapy for lung cancer: a systematic review. (2008) (240)
- Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer (2002) (238)
- Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. (2001) (237)
- Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. (2009) (234)
- Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. (2019) (225)
- The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. (2012) (208)
- A structured review of quality of life instruments for head and neck cancer patients (2001) (192)
- Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer (2014) (188)
- Stage I and II MALT lymphoma: results of treatment with radiotherapy. (2001) (180)
- Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. (2000) (177)
- Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline (2011) (175)
- Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography. (2009) (168)
- Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. (2012) (166)
- Predictive model for survival in patients with advanced cancer. (2008) (165)
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020) (165)
- Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18. (2005) (164)
- Cone-beam computed tomographic image guidance for lung cancer radiation therapy. (2009) (159)
- Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). (2002) (158)
- Logistics of collecting patient-reported outcomes (PROs) in clinical practice: an overview and practical examples (2009) (150)
- Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. (2003) (145)
- Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. (2015) (144)
- Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis (2005) (138)
- No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. (2014) (137)
- Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy (2003) (134)
- Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers (2011) (133)
- Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction With Doctor Questionnaire. (1999) (133)
- The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer. (2013) (132)
- Symptom response after palliative radiotherapy for patients with brain metastases. (2002) (124)
- Communicating quality of life information to cancer patients: a study of six presentation formats. (2005) (124)
- Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline (2004) (121)
- Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in Stereotactic Lung Radiation Therapy (2006) (121)
- Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. (2015) (111)
- The psychosocial impact of stigma in people with head and neck or lung cancer (2013) (111)
- Oncologists' use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians (2004) (107)
- The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. (2009) (98)
- Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial. (2014) (95)
- Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer. (2000) (94)
- Effect of immobilization and performance status on intrafraction motion for stereotactic lung radiotherapy: analysis of 133 patients. (2011) (93)
- A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. (2002) (93)
- Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome? (2012) (91)
- Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy. (2010) (90)
- Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. (2009) (89)
- The use and toxicity of steroids in the management of patients with brain metastases (2008) (89)
- Context moderates illness‐induced lifestyle disruptions across life domains: a test of the illness intrusiveness theoretical framework in six common cancers (2006) (87)
- Prognostic Factors for Cure, Recurrence and Long-Term Survival After Surgical Resection of Thymoma (2014) (86)
- Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. (2000) (84)
- Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC) (2016) (83)
- The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. (2008) (81)
- A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma (2005) (78)
- A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy. A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial. (2004) (78)
- Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? (2005) (77)
- Physicians' perspective on quality of life: An exploratory study of oncologists (1996) (76)
- Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. (2007) (76)
- Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. (2007) (76)
- Value of whole brain re-irradiation for brain metastases--single centre experience. (2007) (76)
- Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10. (2008) (72)
- Interpreting differences in quality of life: The FACT-H&N in laryngeal cancer patients (2004) (70)
- Efficacy and Toxicity Analysis of NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC) (2016) (68)
- Prognostic significance of thymomas in patients with myasthenia gravis. (2002) (66)
- Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. (2004) (64)
- Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial. (2004) (64)
- Travelling for radiation cancer treatment: Patient perspectives (2003) (61)
- Comparison of spine, carina, and tumor as registration landmarks for volumetric image-guided lung radiotherapy. (2009) (60)
- Effects of genistein following fractionated lung irradiation in mice. (2009) (57)
- Tumor Regression and Positional Changes in Non-small Cell Lung Cancer During Radical Radiotherapy (2011) (56)
- Cancer patients' preferences for communicating clinical trial quality of life information: A qualitative study (2003) (56)
- Effect of image-guidance frequency on geometric accuracy and setup margins in radiotherapy for locally advanced lung cancer. (2011) (55)
- A novel four-dimensional radiotherapy method for lung cancer: imaging, treatment planning and delivery (2006) (54)
- Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: a retrospective review. (2003) (53)
- Treatment of the Elderly When Cure is the Goal: The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer (2011) (53)
- Fatal injuries and alcohol. (1985) (52)
- Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (2020) (52)
- Radiotherapy for brain metastases: defining palliative response. (2001) (52)
- Radiation Therapy Definitions and Reporting Guidelines for Thymic Malignancies (2011) (51)
- Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy (2012) (50)
- Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer. (2005) (49)
- Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases. (2009) (49)
- Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy. (2001) (49)
- Psychometric refinement of an outpatient, visit‐specific satisfaction with doctor questionnaire (2004) (48)
- Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. (2009) (48)
- The Ability of Existing Questionnaires to Measure Symptom Change After Paracentesis for Symptomatic Ascites (2007) (46)
- Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC (2012) (46)
- Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care. (2015) (46)
- Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma (2010) (45)
- Practical Considerations Arising from the Implementation of Lung Stereotactic Body Radiation Therapy (SBRT) at a Comprehensive Cancer Center (2008) (43)
- Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT) (2016) (43)
- Alleviating Emotional Exhaustion in Oncology Nurses: an Evaluation of Wellspring’s “Care for the Professional Caregiver Program” (2012) (42)
- A Preliminary Survey of Oncologists' Perceptions of Quality of Life Information (1997) (41)
- Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer (2008) (40)
- Intensity-modulated radiotherapy in the treatment of lung cancer. (2012) (40)
- Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review. (2005) (40)
- Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy. (2011) (39)
- Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience. (2007) (39)
- Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group. (2007) (38)
- Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial. (2009) (37)
- Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spine. (2009) (37)
- Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial. (2015) (36)
- Quality-of-life information and clinical practice: the oncologist's perspective. (1998) (36)
- The role of palliative thoracic radiotherapy in non-small cell lung cancer. (1996) (36)
- Stereotactic Body Radiation Therapy for Medically Inoperable Early-stage Lung Cancer Patients: Analysis of RTOG 0236 (2009) (35)
- CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS). (2016) (35)
- Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy? (2004) (34)
- Consensus statement on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control. (2012) (34)
- Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single‐Institution Experience (2018) (33)
- Long-Term Outcome after En Bloc Resection of Non–Small-Cell Lung Cancer Invading the Pulmonary Sulcus and Spine (2013) (33)
- Superior vena cava syndrome. (2009) (33)
- Stereotactic Body Radiotherapy in Patients with Previous Pneumonectomy: Safety and Efficacy (2014) (33)
- Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancer. (2011) (32)
- Toxicity Analysis of RTOG 0236 Using Stereotactic Body Radiation Therapy to Treat Medically Inoperable Early Stage Lung Cancer Patients (2007) (31)
- Quality of life and utility in irradiated laryngeal cancer patients. (2000) (30)
- Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma. (2015) (30)
- Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer. (2014) (29)
- A multicenter assessment of the adequacy of cancer pain treatment using the pain management index. (2010) (28)
- Decision making in palliative radiation therapy: reframing hope in caregivers and patients with brain metastases (2006) (28)
- Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and goo (2016) (28)
- Waiting Lists for Radiation Therapy: A Case Study (2001) (28)
- Spontaneous regression in advanced non-small cell lung cancer (2010) (27)
- Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy (2017) (26)
- Incidental prophylactic nodal irradiation and patterns of nodal relapse in inoperable early stage NSCLC patients treated with SBRT: a case-matched analysis. (2014) (25)
- Defining the impact and contribution of steroids in patients receiving whole-brain irradiation for cerebral metastases. (2004) (25)
- Advanced lung cancer patients’ experience with continuity of care and supportive care needs (2013) (25)
- Do ongoing lifestyle disruptions differ across cancer types after the conclusion of cancer treatment? (2011) (25)
- International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control. (2010) (24)
- The Difficulties of a Randomized Study in Superior Vena Caval Obstruction (2007) (24)
- Does tumor status influence cancer patients’ satisfaction with the doctor-patient interaction? (2004) (23)
- Primary treatment endpoint following palliative radiotherapy for painful bone metastases: need for a consensus definition? (2002) (23)
- Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma. (2004) (23)
- Setup reproducibility for thoracic and upper gastrointestinal radiation therapy: Influence of immobilization method and on-line cone-beam CT guidance. (2010) (22)
- The development and validation of a quality-of-life questionnaire for head and neck cancer patients with enteral feeding tubes: the QOL-EF (2011) (22)
- Informed consent for clinical trials: is simpler better? (1998) (21)
- Predicting Radiation Esophagitis Using 18F‐FDG PET During Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer (2016) (21)
- Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy. (2015) (21)
- Computerized tomographic simulation compared with clinical mark-up in palliative radiotherapy: a prospective study. (2006) (20)
- The Influence of Sex on Efficacy, Adverse Events, Quality of Life, and Delivery of Treatment in National Cancer Institute of Canada Clinical Trials Group Non-small Cell Lung Cancer Chemotherapy Trials (2010) (20)
- Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapy. (2014) (20)
- Role of palliative radiotherapy in the management of mural cardiac metastases: who, when and how to treat? A case series of 10 patients (2016) (20)
- Primary gastric lymphoma: brief overview of the recent Princess Margaret Hospital experience. (2000) (20)
- Travelling for radiation cancer treatment: patient satisfaction. (2005) (20)
- Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer. (2009) (20)
- The palliative uses of radiation therapy in surgical oncology patients. (2001) (19)
- Randomized study of single versus fractionated radiotherapy (RT) in the palliation of non-small cell lung cancer; NCIC CTG SC.15 (2001) (18)
- Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy. (2014) (17)
- Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer. (2018) (17)
- Positron Emission Tomography with 18Fluorodeoxyglucose in Radiation Treatment Planning for Non-small Cell Lung Cancer: A Systematic Review (2011) (17)
- A one-step cone-beam CT-enabled planning-to-treatment model for palliative radiotherapy-from development to implementation. (2012) (17)
- Understanding the needs of lung cancer patients during the pre-diagnosis phase (2012) (17)
- The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer (2004) (16)
- Do behavioural self-blame and stigma predict positive health changes in survivors of lung or head and neck cancers? (2013) (16)
- Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinoma. (2012) (16)
- Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer (2009) (16)
- A phase I study of concurrent pemetrexed (P)/cisplatin (C)/radiation (RT) for unresectable stage IIIA/B non-small cell lung cancer (NSCLC) (2008) (15)
- Palliative therapy for lung cancer. (2003) (15)
- Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer. (2012) (15)
- O-154 Impact of maintaining Hb with epoetin alfa on time toprogression (TTP), overall survival (OS), quality of life (QOL) and transfusion reduction in limited disease SCLC patients (2005) (15)
- Prophylactic Cranial Irradiation for Limited‐Stage Small‐Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial (2019) (14)
- Quantifying interobserver variation in target definition in palliative radiotherapy. (2011) (14)
- Malignant Ascites Symptom Cluster in Patients Referred for Paracentesis (2010) (14)
- The success of data collection in the palliative setting—telephone or clinic follow-up? (2003) (14)
- Sex or survival (2010) (14)
- Practice and Policy of Measuring Quality of Life and Health Economics in Cancer Clinical Trials: A Survey among Co-operative Trial Groups (2004) (14)
- How effective is a virtual consultation process in facilitating multidisciplinary decision-making for malignant epidural spinal cord compression? (2012) (13)
- Serial 4DCT/4DPET imaging to predict and monitor response for locally-advanced non-small cell lung cancer chemo-radiotherapy. (2017) (13)
- In the Loop: The Organization of Team-Based Communication in a Patient-Centered Clinical Collaboration System (2016) (13)
- Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy. (2016) (13)
- Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non–small‐cell Lung Cancer (NCT02788461) (2018) (13)
- Volumetric image guidance using carina vs spine as registration landmarks for conventionally fractionated lung radiotherapy. (2012) (13)
- High Dose Rate Brachytherapy as a Treatment Option in Endobronchial Tumors (2016) (13)
- [Radiation therapy definitions and reporting guidelines for thymic malignancies]. (2014) (13)
- Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer. (2016) (12)
- 137 Stage I and II follicular lymphoma: Longterm outcome and pattern of failure following treatment with involved field radiation therapy alone (1999) (12)
- Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U). (2015) (11)
- Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity. (2010) (11)
- Lung sparing and dose escalation in a robust-inspired IMRT planning method for lung radiotherapy that accounts for intrafraction motion. (2013) (11)
- The Choosing Wisely Canada cancer initiative. (2014) (11)
- Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: pilot experience with 18F-fluorodeoxyglucose positron emission tomography-computed tomography. (2011) (11)
- Superior vena cava syndrome. (2010) (11)
- Genetic biomarkers associated with pain flare and dexamethasone response following palliative radiotherapy in patients with painful bone metastases. (2017) (10)
- A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer. (2019) (10)
- Pain and Rib Fracture after Stereotactic Radiotherapy for Peripheral Non-small Cell Lung Cancer (2008) (10)
- Development and evaluation of a combined story and fact-based educational booklet for patients with multiple brain metastases and their caregivers (2011) (9)
- Respiratory Correlated Cone Beam CT in the Assessment of Non-small Cell Lung Cancer during Radiotherapy (2008) (9)
- Assessment of palliation in women with recurrent breast cancer. (1996) (8)
- Image guidance in non-small cell lung cancer. (2010) (8)
- Classification and Reporting of Late Radiographic Changes After Lung Stereotactic Body Radiotherapy: Proposing a New System. (2015) (8)
- A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis (2021) (8)
- National Trends and Dynamic Responses in the Canadian Radiation Oncology Workforce From 1990 to 2018. (2019) (8)
- Computed tomographic simulation in palliative radiotherapy: the Princess Margaret Hospital experience. (2004) (8)
- The Brain Metastases Symptom Checklist as a novel tool for symptom measurement in patients with brain metastases undergoing whole-brain radiotherapy. (2016) (8)
- Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer. (2016) (8)
- Promoting Career Selection Through a Comprehensive Enrichment Experience: A Review of The Canadian Radiation Oncology Summer Studentship. (2020) (7)
- Early Phase in the Development of a Bone Metastases Quality of Life Module (2007) (7)
- Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE) (2022) (7)
- Capturing acute toxicity data during lung radiotherapy by using a patient-reported assessment tool. (2013) (7)
- Leveraging Mobile Technology to Improve Efficiency of the Consent-to-Treatment Process. (2017) (7)
- Genetic biomarkers associated with changes in quality of life and pain following palliative radiotherapy in patients with bone metastases. (2017) (7)
- Has the practice of radiation oncology for locally advanced and metastatic non-small-cell lung cancer changed in Canada? (2010) (7)
- Radiation Pneumonitis in Lung Cancer Patients - The Neglected Patient-Related Variables (2005) (7)
- Excellence in Radiation Research for the 21st Century (EIRR21): description of an innovative research training program. (2012) (7)
- Comparison of 3D Conformal Radiation Therapy (3DCRT) and Intensity Modulated Radiation Therapy (IMRT) in Stage III Non-small Cell Lung Cancer (NSCLC) (2012) (6)
- Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial. (2021) (6)
- Measurement invariance of the Illness Intrusiveness Ratings Scale's three-factor structure in men and women with cancer. (2011) (6)
- Symptom response in non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib: Quality of life analysis of the NCIC CTG BR.21 trial (2005) (6)
- Mentorship Needs for Radiation Oncology Residents: Implications for Programme Design. (2020) (6)
- Early Results of Image-guided Radiation Therapy in Lung Stereotactic Body Radiotherapy (SBRT) (2007) (6)
- Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre (2021) (5)
- Factors influencing the use of single versus multiple fractions of palliative radiotherapy for bone metastases: a 5-year review and comparison to a survey (2003) (5)
- Self management interventions for breathlessness in adult cancer patients (2017) (5)
- Low Incidence of Esophageal Toxicity After Lung Stereotactic Body Radiation Therapy: Are Current Esophageal Dose Constraints Too Conservative? (2018) (5)
- Dosimetric and clinical impact of 3D vs. 2D planning in palliative radiotherapy for bone metastases (2013) (5)
- Quality of life (QOL) impact of adjuvant chemotherapy for early stage non-small cell lung cancer (NSCLC): Final analysis of JBR.10 randomized trial (2007) (5)
- Use of quality-of-life assessment for nasopharyngeal cancer. (2006) (5)
- Thymoma pathology and myasthenia gravis outcomes (2021) (5)
- Harnessing radiation technology to improve survival. (2011) (5)
- Informational stories: a complementary strategy for patients and caregivers with brain metastases (2009) (5)
- Change in symptoms after paracentesis for symptomatic malignant ascites (2005) (5)
- Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: Results from the Phase III CONVERT trial. (2017) (5)
- Mapping the Current State of Canadian Medical School Oncology Interest Groups (2020) (5)
- The Clinical Relevance and Management of Grade 2 Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients on Adjuvant Durvalumab (2020) (5)
- Radiotherapy in the management of non-small-cell lung cancer (1993) (5)
- The palliative effect of chemotherapy (CT) in metastatic breast cancer (MBC): objective tumour response is associated with symptom (Sx) improvement (1999) (4)
- The black box: physician response to breast cancer guidelines. (1997) (4)
- Rapidly progressive bone destruction of the finger as first presentation of systemic metastases from lung cancer (2010) (4)
- A Quality Initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Radiotherapy Fractionation for the Palliation of Uncomplicated Painful Bone Metastases (2013) (4)
- Clinical benefit in patients with cancer of the pancreas: How does it compare with clinically significant changes in quality-of-life scores? (2002) (4)
- No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236 (2012) (4)
- OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC (2016) (4)
- O-201 A phase II trial of induction chemotherapy followed by extrapleural pneumonectomy and high-dose hemithoracic radiation for malignant pleural mesothelioma (2003) (4)
- Correlations between target scores and anchor ratings on a health transition questionnaire (2002) (4)
- An open letter to all members of the IASLC. (2004) (4)
- Meta-analysis of single-fraction versus multi-fraction radiotherapy trials for palliation of painful bone metastases (2001) (4)
- Assessment of palliation in patients with lung cancer: Comparisons between patient symptom diary scores and “minimum clinical change” in quality-of-life scores (2002) (4)
- The Role of Specialized Palliative Radiotherapy (RT) Programs: A Decade of Experience in a Tertiary Oncology Center (2011) (3)
- Motexafin gadolinium (MGd) combined with whole brain radiation therapy prolongs time to neurologic progression in non- small cell lung cancer (NSCLC) patients with brain metastases: Pooled analysis of two randomized phase III trials (2007) (3)
- Have we forgotten that radiation is an effective therapy for lung cancer? (2013) (3)
- Strategic planning in an academic radiation medicine program. (2017) (3)
- A consensus development approach to define national research priorities in bone metastases: proceedings from NCIC CTG workshop. (2003) (3)
- Alternatives to surgery in early stage disease-stereotactic body radiotherapy. (2013) (3)
- 50 Image-Guided Stereotactic Lung Radiation Therapy (2005) (3)
- Intrafractional Target Position Accuracy for Lung Stereotactic Body Radiotherapy (SBRT) using Cone-beam CT (CBCT) (2009) (3)
- Cons: After lung stereotactic ablative radiotherapy for a peripheral stage I non-small cell lung carcinoma, radiological suspicion of a local recurrence is not sufficient indication to proceed to salvage therapy (2016) (3)
- Impact of induction chemotherapy and adjuvant radiation therapy on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma (2007) (3)
- Motexafin gadolinium prolongs time to neurologic progression in lung cancer patients with brain metastases: results of a randomized phase III trial (2002) (3)
- A radio-sensitive primary osteosarcoma in the lung (2011) (3)
- Genetic biomarkers associated with response to palliative radiotherapy in patients with painful bone metastases. (2017) (3)
- Bone metastases: ongoing controversies in fractionation schedules. (2000) (3)
- MA 09.02 Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy: A Single Institutional Experience (2017) (3)
- Palliative Thoracic Radiotherapy for Lung Cancer: A Systematic Review (2007) (3)
- A Comparison of Hypofractionated and Twice Daily Thoracic Irradiation in Limited-Stage Small Cell Lung Cancer: An Overlap Weighted Analysis. (2021) (2)
- The impact of tobacco retail density on overall survival (OS) in lung cancer survivors. (2020) (2)
- Poster Viewing PresentationQuantifying Inter and Intra-Fraction Tumor Motion using Respiration-Correlated Cone Beam CT in Lung Stereotactic Body Radiotherapy (SBRT) (2007) (2)
- Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non-Small-Cell Lung Cancer (2015) (2)
- 142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS) (2017) (2)
- O-66 Impact of whole brain radiation therapy (WBRT) and motexafin gadolinium (MGd) on neurologic and neurocognitive progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a randomized phase III trial (2003) (2)
- Lung sparing and dose escalation in a robust-inspired IMRT planning method for lung radiotherapy that accounts for intrafraction motion. (2013) (2)
- Exploring the geriatric needs of oncology inpatients at an academic cancer centre. (2019) (2)
- Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus? (2022) (2)
- Confirmatory factor analysis and clinical significance of the illness intrusiveness ratings scale in men and women with common cancer diagnoses (2002) (2)
- Minimal important difference: Can we predict its magnitude? (2002) (2)
- Reply to T. Sio et al. (2019) (2)
- Towards a One-Step Scan and Treat Process for Palliative Radiotherapy - a Potential Application for Cone Beam Computerized Tomography (CBCT) (2005) (2)
- Adaptive Dose-Escalation Using Serial 4D-PET/CT Scans During Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer (2014) (2)
- Trimodality Approach to Stage IIIA-N2 NSCLC: As Good as It Gets? (2016) (2)
- O-63 Brain metastases as the initial site of failure in locally advanced non-small cell lung cancer treated with combined modality therapy: Implications for prophylactic cranial irradiation (2003) (2)
- Retrospective Evaluation of Setup Reproducibility for Thoracic and Upper Gastrointestinal Radiotherapy Through Volumetric Imaging: Stability and Dependence on Immobilization (2007) (2)
- The Impact of Evolving Image-Guidance Processes on Initial Patient Setup for Lung Radiotherapy. (2011) (2)
- In reply to Zagar and Marks. (2012) (2)
- Strategic Training in Transdisciplinary Radiation Science for the 21st Century (STARS21): 15-year Evaluation of an Innovative Research Training Program. (2021) (2)
- Radiotherapy Induced Bone Injury (RIBI) as a Late Side Effect in Patients Treated with Stereotactic Lung Radiotherapy (2010) (1)
- Validating impact of pretreatment tumor growth rate on outcome of early‐stage lung cancer treated with stereotactic body radiation therapy (2020) (1)
- A Pilot Prospective Study of Metabolic and Anatomic Response using FDG PET CT before, during and after Radiotherapy in Lung Cancer (2008) (1)
- Lung cancer with synchronous solitary brain metastasis: palliative or radical treatment? (2004) (1)
- Abstracts of the MASCC/ISOO 2017 Annual Meeting (2017) (1)
- Preferences for short versus long - term androgen deprivation in prostate cancer survivors. (2004) (1)
- Stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) (2008) (1)
- Quality of life (QoL) for FDA-approved agents in advanced NSCLC. (2016) (1)
- High Dose Rate Brachytherapy in the Management of Endobronchial Tumors: Princess Margaret Cancer Center Experience (2015) (1)
- A Phase 3, Multicenter, Randomized Trial to Evaluate the Symptomatic and Quality of Life Improvements in Lung Cancer Patients Receiving External Beam Radiation With or Without High Dose Rate Intraluminal Brachytherapy (2017) (1)
- Lung cancer eight years after radioactive seed migration (2016) (1)
- Lung cancer eight years after radioactive seed migration (2016) (1)
- Automated Tools to Facilitate Lung Cancer Outcomes Data-mining (2010) (1)
- Impairment of neurocognitive function in brain metastases patients: baseline results from the phase III trial with motexafin gadolinium (2001) (1)
- Importance of tumor size in resectable stage III-N2 non-small cell lung cancer. (2022) (1)
- Impact of Pretreatment Growth Rate on Outcome of Stage I Non-small Cell Lung Cancer After Stereotactic Body Radiation Therapy (2012) (1)
- PO-0745 CAN FDG PET DURING THE COURSE OF RADIATION THERAPY FOR LUNG CANCER PREDICT FOR ESOPHAGITIS AND PNEUMONITIS OUTCOME? (2012) (1)
- 11 IMPROVEMENT OF TARGET COVERAGE IN RADICAL LUNG RADIOTHERAPY USING IMAGE GUIDANCE CONE-BEAM CT (CBCT) (2009) (1)
- Risk Adapted Radiation Therapy for Thymoma: A Single-Institution 30 Year Review (2015) (1)
- Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy (2012) (1)
- Treating dural metastases mimicking intracranial hypotension. (2007) (1)
- Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis. (2022) (1)
- Inter and Intra-Fraction Target Localization Using Volumetric Imaging in Stereotactic Body Radiation Therapy (SBRT) in the Lung (2007) (1)
- Prospective Longitudinal Assessment of Quality of Life and Symptoms in Patients With Oligometastatic Cancer Treated With Stereotactic Body Radiation Therapy: Analysis of a Phase 2 Trial (2017) (1)
- Feasibility and Reproducibility of Cone-Beam CT Guided Lung Radiotherapy Using Registration to Bone, Carina, and Tumor (2007) (1)
- Predictors of survival for patients with brain metastases: results of a randomized phase III trial (2002) (1)
- Prolonged progression free interval in a patient with locally recurrent small cell lung cancer presenting with cerebellar paraneoplastic syndrome (2015) (1)
- Thoracic radiotherapy with 5 fractions may have palliative and survival benefits over single-fraction radiotherapy for people with lung cancer (2003) (1)
- Sci—Thurs PM: Planning—06: A Simple, Robust IMRT Optimization Method for Lung Cancer, Accounting for Tissue Heterogeneity and Intra‐Fraction Lung Tumour Motion (2009) (1)
- Sex: Taboos, Assumptions, and Evidence. (2015) (1)
- Concurrent Pemetrexed/Cisplatin/Radiation for Unresectable Stage IIIA/B Non-Small Cell Lung Cancer: A Phase I/II Study (2007) (1)
- Prognostic factors in brain metastases: can we determine predictors of early death (2001) (1)
- Quantifying the Benefits of Adaptive Radiotherapy on Lung Sparing for Thoracic Tumors (2008) (1)
- Enhancing Continuity of Care with the Use of Palliative Radiotherapy Treatment Summaries (PaRTS) (2015) (1)
- Factors that Influence the Acceptability of Telemedicine as a means to Evaluate Treatment Outcome for Patients Completing Palliative Radiotherapy (2014) (1)
- A Q-TWiST analysis of adjuvant chemotherapy in non-small cell lung cancer (NSCLC) in the NCIC CTG JBR.10 trial (2008) (1)
- A phase II prospective study of standardized steroid dosing for patients with brain metastases undergoing whole brain radiotherapy (2008) (1)
- Mapping the Current State of Canadian Medical School Oncology Interest Groups (2020) (1)
- Long-term outcome after resection of non-small cell lung cancer invading the thoracic inlet. (2014) (1)
- A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer (RTOG 0214): How to Improve Accrual to an Important Prospective Randomized Study (2005) (1)
- Patterns of Failure and Salvage Therapy in Stereotactic Body Radiotherapy for Stage I Non–small Cell Lung Cancer (2009) (1)
- A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer. (2022) (1)
- Outcomes of Bimodality and Trimodality Therapy in Patients with Stage III Non-small Cell Lung Cancer (NSCLC) (2010) (1)
- Prognostic Value of Pretreatment Neutrophil-Lymphocytes Ratio on Outcomes in Lung SBRT (2015) (1)
- Investigating the Early Metabolic Response of Non-small Cell Lung Cancer (NSCLC) to Stereotactic Body Radiation Therapy (SBRT) (2008) (1)
- 133: Incidence, Severity and Management of Pneumonitis in Stage Iii Lung Cancer Patients on Adjuvant Durvalumab (2020) (1)
- Stereotactic radiotherapy for brain metastases: a true therapeutic breakthrough or.... (2001) (1)
- Tobacco retail availability and tobacco cessation in lung and head and neck (HN) cancer survivors. (2019) (1)
- O-248 How should palliation be measured — illustrative examples from the NCIC CTG palliative thoracic radiation trial (2003) (1)
- 2023 The impact of 3 dimensional CT planning on radiotherapy for bone metastases (2009) (0)
- Health Related Quality of Life Outcomes Following Stereotactic Body Radiotherapy in Patients with Oligo-Metastatic Disease: An Individual Patient Data Meta-Analysis (2022) (0)
- PC 02.03 PCI---YES (2017) (0)
- Online Palliative Radiotherapy Planning and Treatment using Cone-beam Computerized Tomography (CBCT) (2008) (0)
- Palliative Radiation for Spinal Metastases: Does the Presence of Soft Tissue Disease Affect the Choice of Treatment Dose and Fractionation? (2013) (0)
- Impact of Tumor Size and Volume on Outcomes following Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer (2011) (0)
- Dose Escalation in Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Using 4D FDG PET/CT: A Planning Study (2016) (0)
- Lung Cancer Management Clinical and research priorities for combined modality therapy in stage III NSCLC (2016) (0)
- Patient Oriented Prostate Utility Scale (2018) (0)
- MA18.07 Awareness of the Harms of Continued Smoking Among Lung Cancer (LC) Survivors (2018) (0)
- Preferences for short versus long - term androgen deprivation in prostate cancer survivors (2004) (0)
- A Phase III Randomized Trial of Palliative Radiation for Advanced Central Lung Tumors with Intentional Avoidance of the Esophagus (PROACTIVE) (2020) (0)
- Stereotactic body radiotherapy (SBRT) and medical inoperability of early stage non-small cell lung cancer. (2006) (0)
- Volume Contents, Volume 10, 2001 (2004) (0)
- SP-0056: SBRT for lung metastases - patient selection and evidence needed (2013) (0)
- P-808 Concurrent medications as potential modifiers of radiation pneumonitis in lung cancer patients (2005) (0)
- The prognostic effects of performance status (PS) and quality of life (QoL) scores on progression-free survival (PFS) and overall survival (OS) in advanced ovarian cancer. (2006) (0)
- Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy (2021) (0)
- Role of FDG-PET as an Early Imaging Biomarker of Esophagitis and Pneumonitis During the Course of Radiation Therapy for Lung Cancer (2012) (0)
- Esophageal Toxicity in Thoracic Stereotactic Radiation Therapy (2017) (0)
- 2507 : A Comparison of Helical and 4DCT Derived Treatment Plans for Lung Stereotactic Body Radiotherapy (2006) (0)
- Patterns of Failure in Patients with Limited-Stage Small Cell Lung Carcinoma (2010) (0)
- Gemcitabine Plus Vinore lb ine Compared With Cisplat in Plus Vinore lb ine or Cisplat in Plus Gemci tabine for Advanced Non – Smal l-Cel l Lung Cancer : A Phase III Tria (2003) (0)
- Mentorship Needs for Radiation Oncology Residents: Implications for Program Design (2018) (0)
- 82 ASSESSMENT OF INTRA-FRACTION TARGET POSITION ACCURACY FOR LUNG STEREOTACTIC BODY RADIOTHERAPY (SBRT) USING CONE-BEAM CT (CBCT) (2009) (0)
- 48 Value of Whole Brain Re-Irradiation for Brain Metastases (2005) (0)
- Dosimetric and Clinical Parameters Contributing to Esophagitis and Radiation Pneumonitis following Treatment for Small-cell Lung Carcinoma (2009) (0)
- Quality of Life Outcomes Following Stereotactic Body Radiotherapy in Patients with Oligo-Metastatic Disease: A Systematic Review and Meta-Analysis. (2021) (0)
- O-033PATIENTS WITH STAGE IIIA (N2) NON-SMALL-CELL LUNG CANCER SELECTED FOR NEOADJUVANT CHEMORADIATION AND SURGERY HAVE IMPROVED SURVIVAL COMPARED TO PATIENTS TREATED WITH DEFINITIVE CHEMORADIATION (2014) (0)
- Effect of Breathing Motion on Dose Accumulation in the Lung Bronchial Tree (2009) (0)
- Reliability and Validity of the PORPUS, a Combined Psychometric and Utility-Based Quality-of-Life Instrument for Prostate Cancer (2006) (0)
- 181 Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma (2006) (0)
- 41 – Palliative Radiotherapy for Lung Cancer (2018) (0)
- Survival a nd N eurologic O utcomes i n a R andomized T rial o f Motexafin G adolinium a nd W hole-Brain R adiation T herapy i n Brain M etastases (2003) (0)
- Reasons for Screen Failure among Patients Identified as Candidates for a Phase 2 Study of 5-fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastatic Cancer (2018) (0)
- Understanding the needs of lung cancer patients during the pre-diagnosis phase (2012) (0)
- 15 IMPACT OF DAILY VOLUMETRIC IMAGING IN REDUCING SET-UP MARGINS FOR LUNG CANCER PATIENTS TREATED WITH CONVENTIONALLY FRACTIONATED RADIOTHERAPY (2009) (0)
- 198 Patients' and health care professionals' perspectives on the most important quality of life issues in bone metastases (2006) (0)
- Specific Growth Rate in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy (SBRT) (2016) (0)
- 145 How to improve accrual to an important prospective randomized study: Prophylactic Cranial Irradiation (PCI) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) - RTOG 0214 (2005) (0)
- Cancer patients’ attitudes, knowledge, and preferences for smoking cessation (SC). (2015) (0)
- Image-guided lung radiotherapy: Bringing technology into routine clinical practice (2007) (0)
- 195 Retrospective review of delays in diagnostic work-up and treatment decision (2005) (0)
- Does Early Tumor Regression Observed on Cone Beam Computed Tomography During Chemoradiation Therapy Predict Favorable Outcome in Locally Advanced Lung Adenocarcinoma (2016) (0)
- 131: Limited-Stage Small Cell Lung Cancer: Outcomes Associated with Prophylactic Cranial Irradiation Over A 20-Year Period At A Single Institution (2020) (0)
- mpact of lymph node metastasis on outcome after xtrapleural pneumonectomy for malignant pleural esothelioma arc (2006) (0)
- Outcomes in Patients With Stage III Non-Small Cell Lung Cancer Treated With Neoadjuvant Concurrent Chemotherapy and Radiation Therapy Followed by Surgical Resection (2015) (0)
- Favourable health-related quality of life reported in survivors of thymic malignancies† (2018) (0)
- Malignant Epidural Spinal Cord Compression: Prognostic Factors Predicting Need for Surgery (2014) (0)
- Abstracts reprinted from journal of clinical oncology (2007) (0)
- P2.02-046 Prognostic Value of Early Tumor Regression during Chemo-Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Topic: Prognostic Factor (2017) (0)
- OA13.05 Prophylactic Cranial Irradiation (PCI) for Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 CONVERT Trial (2018) (0)
- Mucosa-associated lymphoid tissue (MALT) lymphomas: treatment results for localized disease (2000) (0)
- Treatment of the elderly when cure is the goal: The influence of age on treatment selection and efficacy for stage III non-small cell lung cancer (NSCLC). (2010) (0)
- 12 PRINCESS MARGARET HOSPITAL EXPERIENCE WITH LUNG STEREOTACTIC BODY RADIOTHERAPY FOR EARLY STAGE NONSMALL CELL LUNG CANCER (2009) (0)
- 26 A quality of life module for enteral feeding: Reliability and validity assessment (2006) (0)
- Cone Beam CT Image Guidance Strategies in Non-breath Hold Stereotactic Liver Radiotherapy (2008) (0)
- 85 PRE-RADIATION TREATMENT PET/CT SCAN CAN PREDICT THE LOCALIZATION OF RESIDUAL DISEASE POST-TREATMENT IN LUNG CANCER (2009) (0)
- Evaluation of Lung IMRT Plan Using NTCP and gEUD Based on Internal Target Volume Delineated From Four-Dimensional Computed Tomography (2007) (0)
- P3-198: An audit of elective mediastinal lymph node irradiation in stage III non-small cell lung cancer patients entered onto a prospective randomized phase III study (2007) (0)
- Radiotherapy for Lung Metastases: Conventional to Stereotactic Body Radiation Therapy. (2023) (0)
- FLT-PET/CT in Non-Small Cell Lung Cancer treated with stereotactic body radiotherapy- A Pilot study. (2022) (0)
- ACP Journal Club. Screening with spiral CT did not reduce lung cancer mortality in older male smokers. (2009) (0)
- 393 Princess Margaret Hospital (PMH) experience with thymomas over a 28-year period (1997) (0)
- 51: A Phase Iii Randomized Trial of Palliative Radiation for Advanced Central Lung Tumours with Intentional Avoidance of the Esophagus (Proactive) (2020) (0)
- P-930 Results of induction chemoradiation followed by surgery forStage 3A-N2 non-small cell lung cancer (2005) (0)
- Dosimetric Effects Of Interfractional Patient Setup Error On Target And Spinal Canal Dose In Locally Advanced Lung Cancer Patients (2011) (0)
- Evolution and Evaluation of a Structured Applied Physics Course for Radiation Oncology and Radiation Physics Trainees (2022) (0)
- SU-DD-A3-06: Assessment of Lung Tumor and Diaphragm Motion Using Cone-Beam CT and 4DCT (2006) (0)
- 146 An audit of Prophylactic Cranial Irradiation (PCI) in limited disease small cell lung cancer: Do we practice what we preach? (2005) (0)
- Phase 2 Study of Normal Tissue Tolerance-Adapted 5-Fraction Stereotactic Body Radiation Therapy (SBRT) for Extracranial Oligometastases (2016) (0)
- Radiotherapy for Thoracic Malignancies (2014) (0)
- The Role of IMRT in Lung Cancer : Guideline Recommendations (2015) (0)
- Clinical and research priorities for combined modality therapy in stage III NSCLC. (2016) (0)
- 136 DOSIMETRIC COMPARISON OF DIFFERENT DOSE PRESCRIPTIONS AND BEAM WEIGHTINGS FOR VOLUMETRIC TREATMENT PLANS FOR VERTEBRAL METASTASES (2009) (0)
- BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer treated with External Beam Radiation With or Without High Dose Rate Intraluminal Brachytherapy. (2023) (0)
- Palliative radiation for bone metastases-does pain response reflect the full clinical benefit (2002) (0)
- Localized head and neck lymphomas — Analysis of prognostic factors and treatment outcome (1991) (0)
- Reply to B. Jeremic et al. (2016) (0)
- Genetic Polymorphisms Associated With Toxicity Are Associated With Overall Survival Following Curative Radiation for Non-Small Cell Lung Cancer (2014) (0)
- 45 A pilot study on reducing radiation therapy planning timelines (2006) (0)
- 3’-Deoxy-3’-(18F) Fluorothymidine Positron Emission Tomography/Computed Tomography in Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy: A Pilot Study (2022) (0)
- P-785 An audit of pophylactic cranial irradiation (PCI) in limited disease small cell lung cancer: Do we practice what we preach? (2005) (0)
- 212 Methods to reduce intestinal morbidity from radiation therapy to unilateral pelvic bone metastases: An investigation to assess feasibility (2006) (0)
- Letter to the editorLetters to the editor (2000) (0)
- Evaluating a structured applied physics case-based course for radiation oncology and radiation physics residents (2022) (0)
- Effect of Breathing Motion on SBRT Dose Accumulation within the Human Thorax (2010) (0)
- Is Daily Cone-beam CT Image Guidance Required to Correct Setup Error in Conventionally Fractionated Lung Radiotherapy? (2008) (0)
- The 3 rd Annual Ontario Thoracic Cancer Conference at Niagara-onthe-Lake (2008) (0)
- Serial 4-Dimensional (4D) Computed Tomography/4D Positron Emission Tomography Imaging to Predict and Monitor Response for Locally Advanced Non-Small Cell Lung Cancer Radiation Therapy (2016) (0)
- A two-dimensional model of disrupted body integrity: initial evaluation in head and neck cancer (2018) (0)
- P1-097: 18Fluorodeoxyglucose Positron Emission Tomography and co-registered computed tomography for radiation treatment planning in lung cancer: a systematic review (2007) (0)
- Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary Authorships. (2021) (0)
- 105 Technique of hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma (2005) (0)
- O-123 Hemithoracic radiotherapy for mesothelioma — challenges and solutions (2003) (0)
- SP-0003: Update on current consensus agreement on lung palliative radiotherapy (2015) (0)
- O-149 4D Radiotherapy for lung cancer: Imaging, treatment planning,and delivery (2005) (0)
- Alleviating Emotional Exhaustion in Oncology Nurses: an Evaluation of Wellspring’s “Care for the Professional Caregiver Program” (2011) (0)
- A Comparative Study of Quality of Life in Patients with Low-and Intermediate-Risk Prostate Cancer: Stereotactic Radiotherapy vs. High Dose-Rate Brachytherapy Monotherapy vs. High Dose-Rate Brachytherapy Boost (2018) (0)
- MA 16.03 Health Utility Scores in Patients with Thymic Malignancies Treated with Multimodality Therapy (2017) (0)
- 236: Validity of Specific Growth Rate in Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy (SBRT) (2016) (0)
- The Impact of Disease Progression on Health-Related Quality of Life Outcomes in Patients with Oligo-Metastatic Disease at 12-Months post Stereotactic Body Radiotherapy. (2022) (0)
- Impact of Different Image-guided Protocols on Geometric Accuracy of Radiotherapy for Locally-advanced Lung Cancer (2009) (0)
- 25 DEVELOPMENT AND IMPLEMENTATION OF A CONE BEAM CT (CBCT) ENABLED ONE-STEP SIMULATION AND TREATMENT PROCESS FOR BONE METASTASES (BM) (2009) (0)
- 6550 POSTER A phase I study of concurrent pemetrexed/cisplatin/radiation for unresectable stage IIIA/B non-small cell lung cancer (2007) (0)
- P-577 Prophylactic cranial irradiation (PCI) in locally advanced non-small cell lung cancer (RTOG 0214): How to improve accrual to an important prospective randomized study (2005) (0)
- Patient Reported and Clinical Outcomes from 5 Fraction SBRT for Oligometastases - a Prospective Single Institution Study. (2022) (0)
- Evidence-Based Series 21-3-5- EDUCATION AND INFORMATION 2013 The Role of IMRT in Lung Cancer (2013) (0)
- 190 Patterns of Recurrence in Stage III Non-Small Cell Lung Cancer Treated with Definitive IMRT: Experience at an Academic Cancer Centre (2019) (0)
- P1.10-05 Tobacco Retail Availability and Tobacco Cessation Among Lung Cancer Survivors (2019) (0)
- Dosimetry, safety, efficacy and QoL in a study of 5-fraction SBRT for oligometastatic (OM) cancers Pelvic re-irradiation with Stereotactic Ablative Radiotherapy (SABR): outcomes and cumulative doses (2018) (0)
- P2.01-03 Quality of Life Outcomes for FDA-Approved Agents in Advanced Non-Small Cell Lung Cancer (2018) (0)
- 70 Radiation pneumonitis in lung cancer patients treated with high dose radiotherapy — role of concurrent medications (2005) (0)
- 163: Mapping The Current State of Canadian Oncology Interest Groups (2020) (0)
- 107: Repeated Whole Brain Radiation for Small Cell Lung Cancer Patients with New, Recurrent, or Progressive Brain Metastases (2020) (0)
- Assessing the Accuracy of the Carina as a Landmark for Image Matching using Cone-beam CT in Radical Lung Radiotherapy (2009) (0)
- From the guest editor's desk (2003) (0)
- Survival Impact of Prophylactic Cranial Irradiation in Limited-stage Small-cell Lung Cancer (2009) (0)
- A phase I/II study of concurrent pemetrexed/cisplatin/radiation in stage IIIa/b non-small cell lung cancer: P2-165 (2007) (0)
- Tailoring Palliative Radiation Therapy (RT) Towards the End of Life — The Importance of ECOG Performance Status (2012) (0)
- Clinical Outcomes In Stage I Non-small Cell Lung Cancer Patients Managed With Accelerated Hypofractionated Radiotherapy (2011) (0)
- 2220 Radiation treatment planning of gastric malt lymphoma (1999) (0)
- The 3rd Annual Ontario Thoracic Cancer Conference at Niagara-on-the-Lake (2008) (0)
- Radiological Diagnosis of Malignant Spinal Cord Compression — A More Favorable Entity? (2012) (0)
- Radiation for painful bone metastases: Comparison of different measures of palliative response (2004) (0)
- 162: Does Early Tumour Regression Observed on Cone-Beam Computed Tomography During Chemo-Radiotherapy Predict Favourable Outcome in Locally Advanced Lung Adenocarcinoma? (2016) (0)
- Impact of Breathing Motion and Uncertainties on the Accumulated Dose in Lung SBRT (2011) (0)
- NCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting (2008) (0)
- 180 Quality of life and utility assessment for laryngeal cancer patients (1999) (0)
- Poster - Thurs Eve-22: Image guided radiation therapy for lung cancer. (2008) (0)
- 126 FACTORS INFLUENCING DOSE/FRACTIONATION CHOICES FOR PALLIATION OF BONE METASTASES (2009) (0)
- Evaluating the Dosimetric Impact of 3D vs. 2D Planning Techniques in Palliative Radiotherapy (2010) (0)
- 185 CONVERT – a successful international collaboration between the UK NCRI, Groupe Français de Pneumo-Cancérologie, Spanish Lung Cancer Group, EORTC and NCI Canada (2014) (0)
- Dosimetric Variations to Organs at Risk Based on Serial 4DCT Scans During Radiation Therapy Treatment for Patients With Locally-Advanced Non-Small Cell Lung Cancer (2013) (0)
- 181: A Review of a Structured Applied Physics Course for Radiation Oncology and Radiation Physics Trainees (2022) (0)
- Palliative E ffect o f C hemotherapy: O bjective T umor Response I s A ssociated W ith S ymptom I mprovement i n Patients W ith M etastatic B reast C ancer (2000) (0)
- Evidence Based Oncology (2004) (0)
- SP-0214: Central disease ñ enough knowledge for safe SBRT treatment? (2014) (0)
- OA11.06 Two BRM Promoter Polymorphisms Do Not Predict Susceptibility or Prognosis of Thymoma (2018) (0)
- P1-110: The dosimetric effects of changes in thoracic cavity fluid levels during adjuvant hemithoracic intensity modulated radiotherapy following extrapleural pneumonectomy for mesotheliomas (2007) (0)
- 19 Sexual Desire Correlates with Preferences for Short versus Long - Term Androgen Deprivation and Radiotherapy in Prostate Cancer Survivors (2005) (0)
- Stereotactic Body Radiotherapy (SBRT) for Non-small Cell Lung Cancer (NSCLC) -is FDG-PET a Predictor of Outcome? (2010) (0)
- Poster - Thur Eve - 20: Serial FDG 4DPET imaging during radiotherapy in advanced lung cancer patients. (2012) (0)
- Patient recruitment in an oligometastases trial: experience from a phase II study of 5 fraction stereotactic body radiation therapy (SBRT). (2016) (0)
- [Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study]. (2001) (0)
- Limited-Stage Small Cell Lung Cancer: Outcomes Associated with Prophylactic Cranial Irradiation Over a 20-year Period at a Single Institution (2020) (0)
- Safety and Outcomes of Multiple Courses of Stereotactic Body Radiation Therapy to the Lung (2015) (0)
- Rebuttal from Dr. Bezjak and Dr. Giuliani. (2016) (0)
- SBRT: frame-based and image-guided strategies (2013) (0)
- A Prospective Study of MRI Assessment of Post-Radiation Changes Following Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer (2018) (0)
- 40: Radiation Pneumonitis in Patients with Interstitial Lung Disease Treated with Lung Stereotactic Radiation Therapy (2016) (0)
- 202 Research and professional development: Video/phone Conference as a format for advancements in palliative radiotherapy (2006) (0)
- O-036 Superior sulcus (pancoast) tumors treated with combinedtri-Modality therapy: Is there a role for prophylactic cranial irradiation? (2005) (0)
- IBS19.01 Novel Radiotherapy Approaches in Small Cell Lung Carcinoma – Applications to Thoracic, Oligometastatic and Cranial Tumor Control (2019) (0)
- 97 Yet another test?! Does repeat imaging help in the management of lung cancer? (2006) (0)
- Feedback Delivery in an Academic Cancer Centre: Reflections From an R2C2-based Microlearning Course (2021) (0)
- P1.14-016 Assessing the Feasibility of FLT-PET for Evaluation of Non-Small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiotherapy (SBRT) (2017) (0)
- PV-0473: Dosimetry, safety, efficacy and QoL in a study of 5-fraction SBRT for oligometastatic (OM) cancers (2018) (0)
- 84 FACTORS INFLUENCING PROPHYLACTIC CRANIAL IRRADIATION UTILIZATION IN LIMITED STAGE SMALL CELL LUNG CANCER (2009) (0)
- PD5-2-3: Translating research into routine clinical practice: image-guided lung stereotactic radiation therapy for unresectable patients with early stage lung cancer (2007) (0)
- Most troublesome quality of life concerns in patients with brain metastases: baseline results from the phase III trial with motexafin gadolinium (2001) (0)
- Outcomes after Normal Tissue-Adopted 5 Fraction (Fr) Stereotactic Body Radiotherapy (SBRT) for Extra-Cranial Oligometastases - A Prospective Study (2020) (0)
- E-8. Evidence-based palliative radiotherapy (2003) (0)
- 177 Selection of patients for stereotactic lung radiotherapy (SBRT) for early stage non-small cell lung cancer (NSCLC) (2006) (0)
- Dosimetric Comparison of Two-Dimensional (2D) vs. Three-Dimensional (3D) Planning for Bone Metastases (2009) (0)
- Predicting Esophagitis During Radical Lung Radiation Therapy Using 18-FDG-PET (2014) (0)
- P-709 Determining optimal treatment volume margins in moving lungtumours (2005) (0)
- Analysis of Serial FDG 4DPET Images Acquired During Radiation Therapy in Advanced Lung Cancer Patients (2012) (0)
- In Reply to Wang and Rallis. (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrea Bezjak?
Andrea Bezjak is affiliated with the following schools:
